IMCD Group acquires pharmaceutical excipients business in Malaysia

Malaysian excipient distributorMaxwell Pharma has been acquired by the IMCD Group.

IMCD Group has announced the acquisition of pharmaceutical ingredients business Maxwell Pharma in Malaysia.

The family owned business was established more than a decade ago in 2000 and is a distributor of active pharmaceutical ingredients and excipient

IMDC intends to take the reins officially on Septemebr 30th 2012 and will aim to further expand the specialty pharmaceutical ingredients business in the country.

TS Cheah, managing director of the company's Malaysian operations, said: "We are very excited about this new acquisition. As one successful family owned and run business, Maxwell has created a solid market base in APIs and excipients in Malaysia."

IMCD is looking to expand its presence in south-east Asia, having already risen to become one of Europe's leading distributors of pharmaceutical ingredients and supplying excipients globally.

It has interests in speciality solvents, process chemicals, active ingredients and intermediates, while also regularly conducting seminars to help customers with their development challenges.